Our plain-English summary of Surgical series in mesothelioma: navigating between biases, by J. Raskin, P.E. Van Schil, J.P.V. Meerbeeck (Translational Lung Cancer Research, 2023).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: J. Raskin, P.E. Van Schil, J.P.V. Meerbeeck
- Journal: Translational Lung Cancer Research
- Published: 2023;12(2):184-186
- Type of article: Editorial, Comment
- Cited by: 2 articles, as counted by NIH iCite
- Read it: PubMed · Publisher · Free full text
In plain English
This was an editorial, not a new study. It commented on Klotz et al.'s study of mesothelioma patients treated with surgery-based therapy at Heidelberg University Hospital, Germany, from 2001 to 2018. In 2013 the hospital switched from extrapleural pleuropneumonectomy (EPP), which removes the lung, to extended pleurectomy/decortication (EPD), which leaves the lung in place except for visibly invaded parts. The authors described three biases in surgical series: selection bias (reporting on the fittest, earliest-stage patients), comparison bias (the right comparison is a similar unoperated patient), and shrinking denominator bias (patients dropping out along the way). In a cited US trial, 57 of 77 patients (74%) starting chemotherapy reached EPP and 40 (52%) finished. They recommended that future retrospective series include matched non-operated patients with comparable prognostic factors, report modern systemic therapy results for them, and analyse all similar patients by intention to treat or clearly show how and why numbers shrank. They wrote that only prospective series can refute the perception that any surgery in mesothelioma is futile by bias. The article did not discuss asbestos and was not externally peer reviewed.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: editorial commenting on another published study; commissioned by the journal and not externally peer reviewed; no new data
- Who was studied: No population of its own. It commented on Klotz et al.'s single-centre series of mesothelioma patients treated at Heidelberg University Hospital, Germany, from 2001 to 2018.
- Main results:
- The editorial described the Heidelberg change of approach in 2013 from EPP to EPD, a less aggressive procedure in which the lung is left in place except for macroscopically invaded parts.
- The authors argued that surgical series suffer from selection bias because they report on the best patients. They cited the 1999 Sugarbaker et al. series as an example.
- The authors described comparison bias: the ideal comparison for a surgical patient is a similar patient who did not get surgery.
- The authors described shrinking denominator bias, citing a US trimodality trial (not their own study). Of 77 patients who started neoadjuvant chemotherapy, 57 (74%) advanced to EPP and 40 (52%) completed all treatment.
- The authors' conclusion: The authors recommended that future retrospective surgical series include a matched cohort of non-resected patients with prognostic factors as comparable as possible, report results of modern systemic therapy in that cohort, and report an intention-to-treat analysis in all patients with similar characteristics or else clearly show the shrinking denominator with its causes. They stated that only prospective series are able to refute the perception that any surgery in mesothelioma is futile by bias.
Topics
Medical terms in this study, explained in our Lexicon: Mesothelioma.
Related studies
- IgG4-related sclerosing cholangitis: navigating diagnostic dilemmas and the challenge of relapse — X. Ren, X. Jin, et al. (2026)
- Navigating Fertility Preservation in Epithelioid Peritoneal Mesothelioma: A Case Study — D.W. Qiu, Y.J. Lin Lee, et al. (2025)
- Navigating the Foggy Landscape of Epithelioid Peritoneal Mesothelioma: A Proposed Standardized Institutional Algorithm for Multimodal Management — G. D'Annibale, F. Santullo, et al. (2026)
- DREM 2.0: Improved reconstruction of dynamic regulatory networks from time-series expression data — M.H. Schulz, W.E. Devanny, et al. (2012)
- Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases — F. Galateau-Sallé, J.M. Vignaud, et al. (2004)
- Malignant epithelioid vascular tumors of the pleura: report of a series and literature review — P.J. Zhang, V.A. Livolsi, et al. (2000)
Browse more research in Translational Lung Cancer Research, or return to medical research.
How to cite it
Cite the study
J. Raskin, P.E. Van Schil, J.P.V. Meerbeeck. Surgical series in mesothelioma: navigating between biases. Translational Lung Cancer Research 2023;12(2):184-186. doi:10.21037/tlcr-23-34. PMID: 36895921.
Cite our summary
“Surgical series in mesothelioma: navigating between biases.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/surgical-series-in-mesothelioma-navigating-between-biases.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.